Article
Mismatch repair defects as a cause of resistance to cytotoxic drugs.
Expert review of anticancer therapy - 1 Jun 2001
Irving J A, Hall A G
Abstract excerpt
In this short review, we aim to bring together the most recent evidence implicating mismatch repair pathway defects as a cause of drug resistance to a spectrum of chemotherapeutic agents in a variety of cancers. Experimental and clinical studies are discussed and possible strategies that may be employed to overcome the multidrug resistant phenotype afforded by such defects.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
